Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, Elmquist JK
J Hypertens
Polycystic ovarian syndrome (July 7, 2025) Androgen excess: a hallmark of polycystic ovary syndrome (December 13, 2023) Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 to 29 Year (Oct 17, 2022) OZEMPIC (semaglutide) injection, for subcutaneous use
Contraindications Saxenda is contraindicated in the following conditions: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Patients with a prior serious hypersensitivity reaction to liraglutide or to any of the product components Pregnancy Warnings and Precautions Risk of Thyroid C-cell Tumors: If serum calcitonin is measured and found to be elevated, the patient should be further evaluated
The typical candidate has a BMI over 30, or over 27 with weight-related health conditions
people under 18
